3,360
Views
70
CrossRef citations to date
0
Altmetric
Review Article

4,5-Dihydro-1H-pyrazole: an indispensable scaffold

&
Pages 427-442 | Received 15 Mar 2013, Accepted 11 Apr 2013, Published online: 01 Jul 2013

References

  • Dipankar Bardalai PP. Pyrazole and 2-pyrazoline derivatives: potential anti-inflammatory and analgesic agents. Int Res J Pharm App Sci 2012;2:1–8
  • Gökhan-Kelekçi NKS, Yabanoğlu S, Yelekçi K, et al. New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity. Bioorg Med Chem 2009;17:675–89
  • Bansal RK. Heterocyclic chemistry, 5th ed. New Delhi: New Age International; 2010
  • David G, Powers DSC, Demosthenes F, et al. Automated parallel synthesis of chalcone-based screening libraries. Tetrahedron 1998;54:4085–96
  • Lye C, Behr RF, Jarboe CH. Pyrazoles, pyrazolines, pyrazolidines, indazoles and condensed rings. In: Wiley RH, ed. The chemistry of heterocyclic compounds. New York: John Wiley; 1967:180--208
  • Li JT, Zhang XH, Lin ZP. An improved synthesis of 1,3,5-triaryl-2-pyrazolines in acetic acid aqueous solution under ultrasound irradiation. Beilstein J Org Chem 2007;3:1–4
  • Eisinger JBN, Flores J. Fluorescence polarization study of human erythrocyte membranes with 1-phenyl-3-(2-naphthyl)-2-pyrazoline as orientational probe. Biochim Biophys Acta 1981;646:334–43
  • Manish Agrawal PKS, Saraf SK. Synthesis of 1,3,5-trisubstituted pyrazoline nucleus containing compounds and screening for antimicrobial activity. Med Chem Res 2012;21:3376–81
  • Wiley PF. Pyrazoles, pyrazolines, pyrazolones. Kirk-Othmer encyclopedia of chemical technology, 3rd ed. New York: John Wiley & Sons, Inc; 1982:436–53
  • Havrylyuk DZB, Vasylenko O, Zaprutko L, et al. Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity. Eur J Med Chem 2009;44:1396–404
  • Md. Azizur Rahman AAS. Pyrazoline derivatives: a worthy insight into the recent advances and potential pharmacological activities. Int J Pharm sci Drug Res 2010;2:165–75
  • Sobhi H, Esrafili A, Adib M. Extraction and determination of 2-pyrazoline derivatives using liquid phase microextraction based on solidification of floating organic drop. J Pharm Biomed Anal 2008;48:1059–63
  • Guan B, Li JF, Li D, et al. Synthesis and spectrum characteristic of four new organic fluorescent dyes of pyrazoline compounds. Dyes and Pigments 2007;75:93–8
  • Lu ZY, Yuan T-S, Zhu W-G, et al. Carrier-transporting and blue electroluminescence properties of a novel pyrazoline derivative. Chin Phys Lett 2000;17:773–4
  • Joshi G, Pant N, Singh P, et al. Synthesis, characterization and fluorescence studies of 3,5-diaryl substituted 2-pyrazolines. Spectrochimica Acta Part A 2011;78:1075–9
  • Chauhan A, Sharma PK, Kaushik N. Pyrazole: a versatile moiety. Int J ChemTech Res 2011;3:11–17
  • Sun YF, Cui YP. The synthesis, structure and spectroscopic properties of novel oxazolone-, pyrazolone- and pyrazoline-containing heterocycle chromophores. Dyes Pigments 2009;81:27–34
  • Mohamad Yusuf PJ. Synthetic and biological studies of pyrazolines and related heterocyclic compounds. Arabian J Chem 2011:1–44 doi: http://dx.doi.org/10.1016/j.arabjc.2011.09.013
  • Dipankar B, Panneerselvam P, Ashish B. Synthesis, characterization and evaluation of analgesic, anti-inflammatory, ulcerogenic potential of some 2-pyrazoline derivatives. Der Pharm Chem 2012;4:1679–88
  • Lv PC, Li DD, Li Q-S, et al. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents. Bioorg Med Chem Lett 2011;21:5374–7
  • Bhat BA, Puri SC, Saxena AK, et al. Synthesis and biological evaluation of chalcones and their derived pyrazoles as potential cytotoxic agents. Bioorg Med Chem Lett 2005;15:3177–80
  • Johnson M, Younglove B, Lee L, et al. Design, synthesis, and biological testing of pyrazoline derivatives of combretastatin-A4. Bioorg Med Chem Lett 2007;17:5897–901
  • Amr AE, Abdel Latiff NA, Abdalla MM. Synthesis and antiandrogenic activity of some new 3-substituted androstano[17,16-c]-5′-aryl-pyrazoline and their derivatives. Bioorg Med Chem 2006;14:373–84
  • Harinadha Babu VH, Sridevi CS, Joseph A, Srinivasan KK. Synthesis and biological evaluation of some novel pyrazolines. Indian J Pharm Sci 2007;69:470–3
  • Cetin AC, Digrak M. 3-Aryl-5-furylpyrazolines and their biological activities. Heteroatom Chem 2003;14:345–7
  • Imran Ali WAW, Amber K, Ashanul H, et al. Synthesis and synergistic antifungal activities of a pyrazoline based ligand and its copper(II) and nickel(II) complexes with conventional antifungals. Microb Pathog 2012;53:66–73
  • Abdel-Wahab BF, Abdel-Aziz HA, Ahmed EM. Synthesis and antimicrobial evaluation of 1-(benzofuran-2-yl)-4-nitro-3-arylbutan-1-ones and 3-(benzofuran-2-yl)-4,5-dihydro-5-aryl-1-[4-(aryl)-1,3-thiazol-2-yl]-1H-pyrazoles. Eur J Med Chem 2009;44:2632–5
  • John R, Goodell P-B, Brett M, et al. Identification of compounds with anti-west Nile virus activity. J Med Chem 2006;49:2127–37
  • Tasneem Taj RRK, Gireesh TM, Raveendra K, et al. One-pot synthesis of pyrazoline derivatised carbazoles as antitubercular, anticancer agents, their DNA cleavage and antioxidant activities. Eur J Med Chem 2011;46:4366–73
  • Kini SG, Bhatt A, Bryant B, et al. Synthesis, antitubercular activity and docking study of novel cyclic azole substituted diphenyl ether derivatives. Eur J Med Chem 2009;44:492–500
  • Gajanan Wanare RA, Neha K, Ravi R, et al. Synthesis of novel α-pyranochalcones and pyrazoline derivatives as Plasmodium falciparum growth inhibitors. Bioorg Med Chem Lett 2010;20:4675–8
  • Abdul R, Bhat FA, Amir A. Bis-pyrazolines: synthesis, characterization and antiamoebic activity as inhibitors of growth of Entamoeba histolytica. Eur J Med Chem 2009;44:426–31
  • Budakoti AB, Athar F, Azam A. Syntheses and evaluation of 3-(3-bromo phenyl)-5-phenyl-1-(thiazolo [4,5-b] quinoxaline-2-yl)-2-pyrazoline derivatives. Eur J Med Chem 2008;43:1749–57
  • Magda AA, El-Sayed NI, Abdel-Aziz AAM, et al. Synthesis, biological evaluation and molecular modeling study of pyrazole and pyrazoline derivatives as selective COX-2 inhibitors and anti-inflammatory agents. Part 2. Bioorg Med Chem 2012;20:3306–16
  • Reddy MV, Billa VK, Pallela VR, et al. Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors. Bioorg Med Chem 2008;16:3907–16
  • Fedele Manna FC, Adriana B, Daniela S, et al. Inhibition of amine oxidases activity by 1-acetyl-3,5-diphenyl- 4,5-dihydro-(1h)-pyrazole derivatives. Bioorg Med Chem Lett 2002;12:3629–33
  • Chimenti F, Fioravanti R, Bolasco A, et al. Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives. Eur J Med Chem 2008;43:2262–7
  • Kunal Nepali AA, Sapra S, Mittal V, et al. N-(1,3-Diaryl-3-oxopropyl)amides as a new template for xanthine oxidase inhibitors. Bioorg Med Chem 2011;19:5569–76
  • Manna F, Chimenti F, Bolasco A, et al. Inhibition of amine oxidases activity by 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives. Bioorg Med Chem Lett 2002;12:3629–33
  • Kunal Nepali GS, Anil T, Amit A, et al. A rational approach for the design and synthesis of 1-acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazoles as a new class of potential non-purine xanthine oxidase inhibitors. Bioorg Med Chem 2011;19:1950–8
  • Rebecca Brown RF, Jim Blunk KD, Berlin K, et al. Biological activity and active groups of novel pyrazoles, thiosemicarbazones, and substituted thiazoles. Proc Okla Acad Sci 1976;56:15–17
  • Durham NN, Chesnut RW, Haslam DF, Berlin KD. Molecular pathology of disease. Ann Okla Acad Sci 1974;4:77–86
  • Sakthinathan SP, Vanangamudi G, Thirunarayanan G. Synthesis, spectral studies and antimicrobial activities of some 2-naphthyl pyrazoline derivatives. Spectrochimica Acta Part A: Mol Biomol Spectr 2012;95:693–700
  • Suresh Kumar SB, Sushma D, Rajiv K, Himanshu G. Biological activities of pyrazoline derivatives -- a recent development. Rec Patent Anti-Infect Drug Discov 2009;4:154–63
  • Udo Bauer BJE, Ingemar N, Berghult M. Parallel solution phase synthesis of N-substituted 2-pyrazoline libraries. Tetrahedron Lett 2000;41:2713–17
  • Kumari K, Raghuvanshi DS, Jouikov V, Singh KN. Sc(OTf)3-catalyzed, solvent-free domino synthesis of functionalized pyrazoles under controlled microwave irradiation. Tetrahedron Lett 2012;53:1130–3
  • Jawale DV, Pratap UR, Mali JR, Mane RA. Silica chloride catalyzed one-pot synthesis of fully substituted pyrazoles. Chin Chem Lett 2011;22:1187–90
  • Rasheed Ahmad Khera AA, Hummera R, Munawar H, et al. Suzuki Miyaura reactions of N-protected tribromopyrazoles. Efficient and site-selective synthesis of 3,4,5-triaryl-pyrazoles, 3,5-diaryl-4-bromopyrazoles and 5-aryl-3,4-dibromopyrazoles. Tetrahedron 2011;67:5244–53
  • Suryakiran N, Reddy TS, Latha KA, et al. An expeditious synthesis of 3-amino 2H-pyrazoles promoted by methanesulphonic acid under solvent and solvent free conditions. J Mol Catalysis A: Chemical 2006;258:371–5
  • Olivier Mahé ID, Vincent L, Jean-François B. Enantioselective synthesis of bio-relevant 3,5-diaryl pyrazolines. Org Biomol Chem 2012;10:3946–54
  • Wen J, Fu Y, Zhang RY, et al. A simple and efficient synthesis of pyrazoles in water. Tetrahedron 2011;67:9618–21
  • Tinarelli A, Righi P, Rosini G, et al. Regioselective synthesis of 1,3,5- and 1,3,4,5-substituted pyrazoles via acylation of N-Boc-N-substituted hydrazones. Tetrahedron 2011;67:612–17
  • Ismaeil ZH, Soliman FMA, Abd-El Monem SH. Synthesis, antimicrobial and antitumor activity of some 3,5-diaryl and 1,3,5-triaryl-2-pyrazoline derivatives. J Am Sci 2011;10:756–67
  • Abid H, Bandaya B, Mir P, et al. Studies on novel D-ring substituted steroidal pyrazolines as potential anticancer agents. Steroids 2010;75:805–9
  • Tao Liu RC, Jing C, Jun Z, et al. 4,5-Diaryl-3-aminopyrazole Derivatives as Analogs of Combretastatin A-4: synthesis and biological evaluation. Arch Pharm Chem Life Sci 2011;11:279–86
  • Cenzo Congiu VO, Loredana V, Massimo C, Claudio P. Synthesis and in vitro antitumor activity of new 4,5-dihydropyrazole derivatives. Bioorg Med Chem 2010;18:6238–48
  • Lv P-C, Shin J, Yin L, et al. Design, synthesis, and structure--activity relationships of pyrazole derivatives as potential FabH inhibitors. Bioorg Med Chem Lett 2010;20:4657–60
  • Rossella Fioravanti AB, Fedele M, Francesca R, et al. Synthesis and biological evaluation of N-substituted-3,5-diphenyl-2-pyrazoline derivatives as cyclooxygenase (COX-2) inhibitors. Eur J Med Chem 2010;45:6135–8
  • Babasaheb P, Bandgar LKA, Hemant V, et al. Synthesis, biological evaluation, and docking studies of 3-(substituted)-aryl-5-(9-methyl-3-carbazole)-1H-2-pyrazolines as potent anti-inflammatory and antioxidant agents. Bioorg Med Chem Lett 2012;22:1–6
  • Zuhal Ö, Zdemir HBK, Gümüs BX, et al. Altan Bilgin. Synthesis and studies on antidepressant and anticonvulsant activities of some 3-(2-furyl)-pyrazoline derivatives. Eur J Med Chem 2007;42:373–9
  • Raj Kumar D, Sahil S, Rajveer S. Xanthine oxidase inhibitors: a patent survey. Expert Opinion Therapeutic Patents 2011;21:1071–108
  • Rossella Fioravanti AB, Fedele M, Francesca R, et al. Synthesis and molecular modelling studies of prenylated pyrazolines as MAO-B inhibitors. Bioorg Med Chem Lett 2010;20:6479–82
  • Revanasiddappa BC, Subrahmanyam EVS, Satyanarayana D. Synthesis and biological evaluation of some novel 1,3,5-trisubstituted pyrazolines. Eur J Chem 2010;7:295–8
  • Mohamed Ashraf Ali MS, Anees Ahamed S. Synthesis, structural activity relationship and anti-tubercular activity of novel pyrazoline derivatives. Eur J Med Chem 2007;42:268–75
  • Mohmmad Younus Wani ARB, Amir A, Dae Hyung L, et al. Synthesis and in vitro evaluation of novel tetrazole embedded 1,3,5-trisubstituted pyrazoline derivatives as Entamoeba histolytica growth inhibitors. Eur J Med Chem 2012;54:845–54
  • Ali MA, Shahar YM, Siddiqui AA, et al. Synthesis and anti-HIV activity of N′-nicotinoyl--3-(4′-hydroxy-3′-methylphenyl)-5-[substituted phenyl]-2-pyrazolines. Acta Poloniae Pharmaceutica 2007;64:423–8
  • Badri Narayan Acharya DS, Mugdha T, Shrivastava AK, et al. Synthesis and antimalarial evaluation of 1,3,5-trisubstituted pyrazolines. Eur J Med Chem 2010;45:430–8
  • Ratnadeep S, Joshi PGM, Santosh D, et al. Synthesis, analgesic and anti-inflammatory activities of some novel pyrazolines derivatives. Bioorg Med Chem Lett 2010;20:3721–5
  • Shamsuzzaman HK, Dar AM, Nazish S, Sumbul R. Synthesis, characterization, antimicrobial and anticancer studies of new steroidal pyrazolines. J Saudi Chem Soc 2012:1–6 . doi: http://dx.doi.org/10.1016/j.jscs.2012.05.004
  • Mamta Rani YM. Synthesis, studies and in vitro antibacterial activity of some 5-(thiophene-2-yl)-phenyl pyrazoline derivatives. J Saudi Chem Soc 2011:1–7 . doi: http://dx.doi.org/10.1016/j.jscs.2011.09.002
  • Mamta Rani, Mohamad Yusuf, Salman Ahmad Khan, Sahota PP. Synthesis, studies and in-vitro antibacterial activity of N-substituted 5-(furan-2-yl)-phenyl pyrazolines. Arabian J Chem 2011:1–7 . doi: http://dx.doi.org/10.1016/j.arabjc.2010.10.036
  • Woong-Sig Moon, Kyoo-Hyun Chung, Du Jin Seol, et al. Antimicrobial effect of monomers and polymers with azole moieties. J Appl Polym Sci 2003;90:2933–7
  • Sameena Bano KJ, Shamim A, Rathish IG, et al. Synthesis and biological evaluation of some new 2-pyrazolines bearing benzene sulfonamide moiety as potential anti-inflammatory and anti-cancer agents. Eur J Med Chem 2011;46:5763–8
  • Suresh Khode VM, Prashant A, Mahesh P, et al. Synthesis and pharmacological evaluation of a novel series of 5-(substituted) aryl-3-(3-coumarinyl)-1-phenyl-2-pyrazolines as novel anti-inflammatory and analgesic agents. Eur J Med Chem 2009;44:1682–8
  • Sivakumar PM, Seenivasan SP, Kumar V, Doble M. Novel 1,3,5-triphenyl-2-pyrazolines as anti-infective agents. Bioorg Med Chem lett 2010;20:3169–72
  • Mohammad Shaharyar MMA, Bakht MA, Majeed J. Pyrazoline bearing benzimidazoles: search for anticancer agent. Eur J Med Chem 2010;45:114–19

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.